Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 9Unknown 4Recruiting 4Withdrawn 3Terminated 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 43Colorectal Neoplasms 22Breast Neoplasms 22Stomach Neoplasms 21Neoplasms 17Esophageal Squamous Cell Carcinoma 12Neoplasm Metastasis 11Nasopharyngeal Carcinoma 11Lung Neoplasms 11Rectal Neoplasms 9Pancreatic Neoplasms 7Colonic Neoplasms 7Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Osteosarcoma 5Brain Neoplasms 5Small Cell Lung Carcinoma 4Recurrence 4Glioblastoma 4Gastrointestinal Neoplasms 4Precision Cell Immunotherapy 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Diseases 3Digestive System Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 11Rituximab 10Gemcitabine 9Paclitaxel 7Lenalidomide 7Decitabine 7Cytarabine 7Bendamustine Hydrochloride 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Carboplatin 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Antilymphocyte Serum 4tislelizumab 3pomalidomide 3liposomal doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Recurrence × Drug Therapy × Clear all
NCT05059782 2021-09-28

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Xi'an Jiaotong University

Phase NA Unknown
150 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

NCT03297528 2020-03-10

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Peking University People's Hospital

Phase 2 Unknown
40 enrolled

Graft vs Host Disease, Recurrence, Neoplasm, Residual

NCT02997241 2016-12-20

CCTDRP

MyGenostics Inc., Beijing

Phase NA Unknown
500 enrolled
Gastrointestinal

Colonic Neoplasms, Recurrence

NCT02410187 2016-03-03

SBRT for Extra-cranial Oligorecurrent Tumor

Korea Cancer Center Hospital

Phase 2 Unknown
1 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡